Expert Solutions

The healthcare industry is knowledge and technology-driven, and we strive to be at the forefront of it. We have access to some of the most renowned thought leaders and industry experts in the domain, facilitating the exchange of new ideas and valuable knowledge for our clients.

Besides leveraging our external network, we also conduct feasibility studies for our clients who wish to expand into new markets, set up facilities in new regions, understand the supply chain dynamics, and know more about competition in a particular geography.

We have worked with companies across the world, both big and small. We understand the challenges of smaller companies while trying to make their mark in the global landscape. Our wide network helps them access both domestic and international markets with conviction.

We also help companies assess unique and lucrative opportunities for expansion through the inorganic route. Our dossier partnering services allows our clients to be early entrants, saving them months and even years of paperwork.

Our Expert Solutions include

  • Feasibility Studies
  • Key Opinion Leader Access
  • Industry Academia Collaboration

Our Business Services include

  • Business Development
  • CMO
  • CDMO
  • CRO
  • API
  • Sourcing & Partnering for Dossier / ANDA

Select Project

  • Innovative immuno-oncology drug evaluation, market landscaping including discussions with KOLs for a UK based company for a potential strategic alliance with innovator focused Indian company
  • Techno-commercial feasibility study for setting up pharma formulation plant in Sri‐Lanka
  • Techno-commercial feasibility study for setting up a pharmaceutical complex in Ethioia, East Africa
  • Techno-commercials feasibility study for potential investments in various projects under pharma-cluster in Senegal, West Africa
  • Vaccine and insulin market feasibility study for one of the top 10 MNCs for EU region
  • Assessment and re-prioritization of product portfolio for a listed API company based on macro factors and therapeutic competitive landscape
  • A specific therapy-area product selection for Japan market for one of the top Indian companies
  • Nutraceutical market assessment for four geographic areas – US, EU, Japan, and other regulated/semi-regulated countries